Evidence map›Paper›PMID 29718129›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Giardia/Cryptosporidium QUIK CHEK Assay Is More Specific Than Quantitative Polymerase Chain Reaction for Rapid Point-of-care Diagnosis of Cryptosporidiosis in Infants in Bangladesh.

Mamun Kabir, Emtiaz Ahmed, Biplob Hossain, Masud Alam, Shahnawaz Ahmed, Mami Taniuchi, Carol A Gilchrist, Eric R Houpt, A S G Faruque, William A Petri and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Food and waterborne parasitology · 2021
    Review
  9. Use-case scenarios for an anti-Cryptosporidium therapeutic.PLoS neglected tropical diseases · 2021
    Review
  10. Article
  11. Prevalence and Correlates ofOpen forum infectious diseases · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Mamun KabirInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Emtiaz AhmedInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Biplob HossainInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Masud AlamInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Shahnawaz AhmedInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Mami TaniuchiDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Carol A GilchristDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Eric R HouptDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
A S G FaruqueInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
William A PetriDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Rashidul HaqueInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
International Centre for Diarrhoeal Disease Research · BDUniversity of Virginia · US

Funding

FIELD STUDIES OF IMMUNITY TO AMEBIASIS IN BANGLADESHR01AI043596 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAROL A GILCHRIST, William A Petri · 1998 to 2026
$7.7M
NIAID NIH HHS R01 AI043596
6 · The paper itself

Abstract

Background: Cryptosporidium is a major cause of childhood diarrhea. Current modes of cryptosporidiosis diagnosis involve procedures that are costly and require both a well-equipped laboratory and technical expertise. Therefore, a cost-effective, user-friendly, and rapid method for point-of-care detection of Cryptosporidium is desirable. Methods: A total of 832 diarrheal stool specimens collected from 200 children aged <2 years were tested by Giardia/Cryptosporidium QUIK CHEK, enzyme-linked immunosorbent assay (ELISA), and quantitative polymerase chain reaction (qPCR) to compare the performance of the individual techniques. We also tested for the presence of other diarrheal pathogens in qPCR-positive samples with a TaqMan Array Card (TAC) to assess whether Cryptosporidium was the sole causative agent for the diarrheal episodes. Results: Of 832 samples, 4.4% were found positive for Cryptosporidium by QUIK CHEK, 3.6% by ELISA, and 8.8% by qPCR. Using TAC-attributed Cryptosporidium diarrhea as the gold standard, the sensitivities of QUIK CHEK, ELISA, and qPCR were 92.3%, 71.8%, and 100%, respectively; the specificities were 97.1%, 94.3%, and 0%, respectively. Analysis of the qPCR-positive and QUIK CHEK-negative samples by TAC identified other enteropathogens as more likely than Cryptosporidium to be the causative agents of diarrhea. Conclusions: QUIK CHEK was more sensitive and specific than ELISA. While qPCR detected Cryptosporidium in more samples than QUIK CHEK, most of these were instances of qPCR detecting small quantities of Cryptosporidium DNA in a diarrheal episode caused by another enteropathogen. We concluded that QUIK CHEK was comparable in sensitivity and superior in specificity to qPCR for the diagnosis of Cryptosporidium diarrhea.

Indexed as

Antigens, ProtozoanBangladeshCryptosporidiosisCryptosporidiumDiarrheaEnzyme-Linked Immunosorbent AssayGiardiaGiardiasisHumansImmunoassayInfantPoint-of-Care SystemsPolymerase Chain ReactionSensitivity and SpecificityAntigens, Protozoan

Identifiers

PMID29718129
PMCPMC6260161
OpenAlexW2800790535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.